It was on Thursday that PTC Therapeutics announced that it plans to acquire five-year old Agilis Biotherapeutics, a gene-therapy start up. PTC Therapeutics will pay $200 million plus incentives. The company has agreed to pay $50 million in cash and $150 million in stock, with an estimated maximum limit of 9.34 million shares. If that … Continue reading “PTC Therapeutics Announces it Will Buy Agilis Biotherapeutics for $200M”
Biotech & Pharma
Biotech & Pharma
Sage Shares Soar After FDA Gives Green Light for This
Shares of Sage Therapeutics were exploding in Tuesday trading after the Food and Drug Administration…
June 12, 2018
Biotech & Pharma
Stryker Makes Takeover Offer for Rival Boston Scientific Corp.
It was an interesting day for medical device makers Stryker and Boston Scientific Corp. While…
June 11, 2018
Biotech & Pharma
Sanofi Responds to Roseanne’s Ambien Tweet with Epic Response
Sanofi, the maker of Ambien, wasn't taking things sitting down when Roseanne Barr blamed her…
May 30, 2018
Biotech & Pharma
FDA Says Teething Medicines Aren’t Safe for Children
This may not be the best news for parents to read who have teething children,…
May 23, 2018
Biotech & Pharma
Amgen Migraine Preventive Drug gets FDA Approval
The Food and Drug Administration has approved Amgen's drug Aimovig for the prevention of migraines.…
May 17, 2018
Biotech & Pharma
Elliott Management Makes Unsolicited Bid to Take Athenahealth Private
Athenahealth shares saw big gains on Monday after it was revealed that hedge fund Elliott…
May 7, 2018
Biotech & Pharma
Acadia Shares Fall After FDA Launches Safety Review on its Parkinson’s Disease Medication
Shares of biotech giant Acadia Pharmaceuticals were deep in the red in Wednesday trading after…
April 25, 2018
Biotech & Pharma
Merck Just Received an Upgrade from Goldman Sachs for This Reason
Shares of Merck were on the rise in Monday trading after the pharmaceutical giant received…
April 24, 2018
Biotech & Pharma
Novartis Just Made an $8.7 Billion Dollar Bet on this Gene Therapy Company
Novartis and AveXis shares saw big gains in Monday trading after it was announced that…
April 9, 2018
Biotech & Pharma
Incyte Shares Fall after Combo Drug with Merck Failed in Study
Shares of Incyte fell 20% on Friday after a combo therapy with drug giant Merck…
April 7, 2018
Biotech & Pharma
Celgene Loses its President and COO
This week biotech giant Celgene Corporation announced that it's president and chief operating officer, Scott…
April 4, 2018
Biotech & Pharma
Alkermes Shares Collapse as FDA Refuses to Review its MLajor Depressive Disorder Drug
Shares of biotech stock Alkermes were falling into the red on Monday after the Food…
April 2, 2018
Biotech & Pharma
GlaxoSmithKline to Buy Novartis AG’s Stake in Consumer-Health Joint Venture for $13B
One of the biggest headlines in the healthcare arena on Tuesday was that GlaxoSmithKline Plc,…
March 27, 2018